Herb Profile

Arjuna

Terminalia arjuna

Arjuna (Terminalia arjuna) carries a Grade C rating — limited evidence.

Last reviewed: 3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution Use cautiously with diagnosed heart disease unless supervised. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Antioxidant, Cardiovascular, Tonic, Stress resilience
Avoid / review if
Unstable Angina, Heart Failure Without Clinician Oversight, Pregnancy/Breastfeeding Caution
Arjuna monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Use cautiously with diagnosed heart disease unless supervised.
Profile context
antioxidant, cardiovascular, tonic
Next steps

Continue reading

Safety

Safety & Cautions

Use cautiously with diagnosed heart disease unless supervised. Possible additive effects with antihypertensives, nitrates, beta blockers, digoxin like regimens, antiplatelets, or anticoagulants.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Unstable Angina
  • Heart Failure Without Clinician Oversight
  • Pregnancy/Breastfeeding Caution
  • And Planned Surgery When Combined With Anticoagulant Therapy.
  • Potential Additive Blood Pressure
  • Antianginal
  • Antiplatelet
  • And Cardiac Medication Effects
  • Monitor With Cardiovascular Drugs.

Safety classifications

  • Interaction-Aware: Medication or interaction context is explicitly noted.
  • Anticoagulant Caution: Bleeding or anticoagulant-adjacent caution language is present.
  • Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

  • Use cautiously with diagnosed heart disease unless supervised. Possible additive effects with antihypertensives, nitrates, beta blockers, digoxin like regimens, antiplatelets, or anticoagulants.

Safety labels

  • Interaction-Aware
  • Anticoagulant Caution
  • Pregnancy/Breastfeeding Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedOxidative Stress Modulation · Metabolic Regulation · Vascular Function Support

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableUse cautiously with diagnosed heart disease unless supervised.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Narrative review
Risk of Bias
High
Consistency
Not assessed
Strongest recorded design is a narrative review, drawn from 2 recorded studies, none of which measured an outcome in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (3)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 3 of 3 studies.

What the evidence actually shows

This table contains 3 structured sources, including 0 human evidence sources; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Plants Used as Antihypertensive

Verma T et al. · Nat Prod Bioprospect · 2021

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis

Kaur N et al. · Cardiol Res Pract · 2014

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Antimicrobial and anti-inflammatory activity of Terminalia arjuna

R V et al. · Bioinformation · 2023

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

PubMed

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Evidence is most relevant to bark preparations or standardized extracts used in clinical studies. and require source backed dosage review before therapeutic claims.
How Arjuna works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Arjuna Works

How Arjuna WorksArjuna acts on biological target pathways via antioxidant, leading to antioxidant efct.ArjunaBiological TargetBiological pathwayAntioxidantAntioxidant EfctCell protectionMetabolicRegulation
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
  • Oxidative Stress Modulation
  • Metabolic Regulation
  • Vascular Function Support
  • Lipid Metabolism Support
  • Endothelial Function Support

Active Compounds

Key constituents studied in Arjuna, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Arjuna

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Arjuna research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.